188 related articles for article (PubMed ID: 28349547)
21. Prostate cancer detection by TURP after repeated negative saturation biopsy in patients with persistent suspicion of cancer: a case-control study on 75 consecutive patients.
Pepe P; Fraggetta F; Galia A; Grasso G; Aragona F
Prostate Cancer Prostatic Dis; 2010 Mar; 13(1):83-6. PubMed ID: 19901959
[TBL] [Abstract][Full Text] [Related]
22. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J; Högstedt B
Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
[TBL] [Abstract][Full Text] [Related]
23. Multiple repeat prostate biopsies and the detection of clinically insignificant cancer in men with large prostates.
Pietzak EJ; Resnick MJ; Mucksavage P; Van Arsdalen K; Wein AJ; Malkowicz SB; Guzzo TJ
Urology; 2014 Aug; 84(2):380-5. PubMed ID: 24929944
[TBL] [Abstract][Full Text] [Related]
24. Obesity is associated with higher risk of prostate cancer detection in a biopsy population in Korea.
Park J; Cho SY; Lee SB; Son H; Jeong H
BJU Int; 2014 Dec; 114(6):891-5. PubMed ID: 24314095
[TBL] [Abstract][Full Text] [Related]
25. TURP in patients with biopsy-proven prostate cancer: sensitivity for cancer detection.
Bach T; Geavlete B; Pfeiffer D; Wendt-Nordahl G; Michel MS; Gross AJ
Urology; 2009 Jan; 73(1):100-4. PubMed ID: 18718643
[TBL] [Abstract][Full Text] [Related]
26. Obesity and prostate cancer: weighing the evidence.
Allott EH; Masko EM; Freedland SJ
Eur Urol; 2013 May; 63(5):800-9. PubMed ID: 23219374
[TBL] [Abstract][Full Text] [Related]
27. Impact of Metabolic Diseases, Drugs, and Dietary Factors on Prostate Cancer Risk, Recurrence, and Survival: A Systematic Review by the European Association of Urology Section of Oncological Urology.
Campi R; Brookman-May SD; Subiela Henríquez JD; Akdoğan B; Brausi M; Klatte T; Langenhuijsen JF; Linares-Espinos E; Marszalek M; Roupret M; Stief CG; Volpe A; Minervini A; Rodriguez-Faba O
Eur Urol Focus; 2019 Nov; 5(6):1029-1057. PubMed ID: 29661588
[TBL] [Abstract][Full Text] [Related]
28. Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies.
Haese A; Graefen M; Steuber T; Becker C; Noldus J; Erbersdobler A; Huland E; Huland H; Lilja H
J Urol; 2003 Dec; 170(6 Pt 1):2269-73. PubMed ID: 14634394
[TBL] [Abstract][Full Text] [Related]
29. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
30. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Liu J; Li S; Shen W
Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
[TBL] [Abstract][Full Text] [Related]
31. Obesity is associated with risk of progression for low-risk prostate cancers managed expectantly.
Bhindi B; Kulkarni GS; Finelli A; Alibhai SM; Hamilton RJ; Toi A; van der Kwast TH; Evans A; Hersey K; Jewett MA; Zlotta AR; Trachtenberg J; Fleshner NE
Eur Urol; 2014 Nov; 66(5):841-8. PubMed ID: 24954793
[TBL] [Abstract][Full Text] [Related]
32. Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: implications for clinical management.
Aydin H; Zhang J; Samaratunga H; Tan N; Magi-Galluzzi C; Klein E; Jones JS; Zhou M
BJU Int; 2010 Feb; 105(4):476-80. PubMed ID: 19709071
[TBL] [Abstract][Full Text] [Related]
33. Serum levels of sex hormone binding globulin (SHBG) are not predictive of prostate cancer diagnosis and aggressiveness: results from an Italian biopsy cohort.
De Nunzio C; Lombardo R; Albisinni S; Gacci M; Tubaro A
Int Braz J Urol; 2013; 39(6):793-9. PubMed ID: 24456771
[TBL] [Abstract][Full Text] [Related]
34. The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate.
Zhigang Z; Wenlu S
Prostate; 2008 Feb; 68(2):190-9. PubMed ID: 18076024
[TBL] [Abstract][Full Text] [Related]
35. The effects of body mass index on changes in prostate-specific antigen levels and prostate volume over 15 years of follow-up: implications for prostate cancer detection.
Wallner LP; Morgenstern H; McGree ME; Jacobson DJ; St Sauver JL; Jacobsen SJ; Sarma AV
Cancer Epidemiol Biomarkers Prev; 2011 Mar; 20(3):501-8. PubMed ID: 21242331
[TBL] [Abstract][Full Text] [Related]
36. 7 to 10 years' follow-up of 573 patients with elevated prostate-specific antigen (>4 ng/mL) or/and suspected rectal examination: biopsies protocol and follow-up guides.
Kravchick S; Cytron S; Stepnov E; Ben-Dor D; Kravchenko Y; Peled R
J Endourol; 2009 Jun; 23(6):1007-13. PubMed ID: 19456240
[TBL] [Abstract][Full Text] [Related]
37. Body mass index in relation to serum prostate-specific antigen levels and prostate cancer risk.
Bonn SE; Sjölander A; Tillander A; Wiklund F; Grönberg H; Bälter K
Int J Cancer; 2016 Jul; 139(1):50-7. PubMed ID: 26914149
[TBL] [Abstract][Full Text] [Related]
38. Relationship between body size and prostate cancer in a sibling based case-control study.
Liu X; Rybicki BA; Casey G; Witte JS
J Urol; 2005 Dec; 174(6):2169-73. PubMed ID: 16280757
[TBL] [Abstract][Full Text] [Related]
39. Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: results from the REDUCE study.
Moreira DM; Nickel JC; Gerber L; Muller RL; Andriole GL; Castro-Santamaria R; Freedland SJ
Cancer; 2014 Jan; 120(2):190-6. PubMed ID: 24323568
[TBL] [Abstract][Full Text] [Related]
40. Abdominal obesity as risk factor for prostate cancer diagnosis and high grade disease: a prospective multicenter Italian cohort study.
De Nunzio C; Albisinni S; Freedland SJ; Miano L; Cindolo L; Finazzi Agrò E; Autorino R; De Sio M; Schips L; Tubaro A
Urol Oncol; 2013 Oct; 31(7):997-1002. PubMed ID: 21925906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
